CSTL Jul 2024 20.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 01:51PM EDT
Loading interactive chart...
- Business Wire
Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test
FRIENDSWOOD, Texas, June 24, 2024--The latest AGA clinical practice guideline acknowledges the role that TissueCypher can play identifying high-risk Barrett’s esophagus patients.
- Business Wire
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRIENDSWOOD, Texas, June 20, 2024--Castle Biosciences reports inducement grants under Nasdaq Listing Rule 5635(c)(4).
- Business Wire
Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner
FRIENDSWOOD, Texas, June 14, 2024--Castle's founder, president & CEO, Derek Maetzold, has been named an EY 2024 Entrepreneur Of The Year® for the Gulf South region
© 2024 Yahoo. All rights reserved.